Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 22186 AL 22200

Cerebrospinal fluid biomarkers in Alzheimer's disease: are the hypotheses more dynamic than the biomarkers?

Spies PE, Verbeek MM, Olde Rikkert MG, Claassen JA.

J Am Geriatr Soc. 2010 Aug;58(8):1619-20. doi: 10.1111/j.1532-5415.2010.03001.x.

Alzheimer's disease genetics: current knowledge and future challenges

Hollingworth P, Harold D, Jones L, Owen MJ, Williams J.

Int J Geriatr Psychiatry. 2011 Aug;26(8):793-802. doi: 10.1002/gps.2628. Epub 2010 Oct 19.

Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression

Bradley MA, Xiong-Fister S, Markesbery WR, Lovell MA.

Neurobiol Aging. 2012 Jun;33(6):1034-44. doi: 10.1016/j.neurobiolaging.2010.08.016. Epub 2010 Oct 20.

Identifying and validating biomarkers for Alzheimer's disease

Humpel C.

Trends Biotechnol. 2011 Jan;29(1):26-32. doi: 10.1016/j.tibtech.2010.09.007. Epub 2010 Oct 23.

Neurophysiology of Alzheimer's disease: towards understanding the relationship between the EEG phenotype and onset of Alzheimer's disease

Alves TC.

J Neurol Neurosurg Psychiatry. 2011 Jan;82(1):2. doi: 10.1136/jnnp.2010.224030. Epub 2010 Oct 25.

Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer's disease

Wang DC, Sun CH, Liu LY, Sun XH, Jin XW, Song WL, Liu XQ, Wan XL.

Neurobiol Aging. 2012 Jun;33(6):1057-66. doi: 10.1016/j.neurobiolaging.2010.09.013. Epub 2010 Oct 27.

Epigenetic modification is linked to Alzheimer's disease: is it a maker or a marker?

Lee J, Ryu H.

BMB Rep. 2010 Oct;43(10):649-55. doi: 10.5483/BMBRep.2010.43.10.649.

YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease

Craig-Schapiro R, Perrin RJ, Roe CM, Xiong C, Carter D, Cairns NJ, Mintun MA, Peskind ER, Li G, Galasko DR, Clark CM, Quinn JF, D'Angelo G, Malone JP, Townsend RR, Morris JC, Fagan AM, Holtzman DM.

Biol Psychiatry. 2010 Nov 15;68(10):903-12. doi: 10.1016/j.biopsych.2010.08.025.

Deletion of CD14 attenuates Alzheimer's disease pathology by influencing the brain's inflammatory milieu

Reed-Geaghan EG, Reed QW, Cramer PE, Landreth GE.

J Neurosci. 2010 Nov 17;30(46):15369-73. doi: 10.1523/JNEUROSCI.2637-10.2010.

Transforming growth factor beta and soluble endoglin in the healthy senior and in Alzheimer's disease patients

Juraskova B, Andrys C, Holmerova I, Solichova D, Hrnciarikova D, Vankova H, Vasatko T, Krejsek J.

J Nutr Health Aging. 2010 Nov;14(9):758-61. doi: 10.1007/s12603-010-0325-1.

Regions of homozygosity and their impact on complex diseases and traits

Ku CS, Naidoo N, Teo SM, Pawitan Y.

Hum Genet. 2011 Jan;129(1):1-15. doi: 10.1007/s00439-010-0920-6. Epub 2010 Nov 23.

Biomarkers for Alzheimer's disease therapeutic trials

Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, Weiner M, Winblad B, Coley N, Vellas B; Oxford Task Force Group.

Prog Neurobiol. 2011 Dec;95(4):579-93. doi: 10.1016/j.pneurobio.2010.11.005. Epub 2010 Dec 2.

Do extracellular chaperone proteins in plasma have potential as Alzheimer's disease biomarkers?

Thambisetty M.

Biomark Med. 2010 Dec;4(6):831-4. doi: 10.2217/bmm.10.108.

Recent cerebrospinal fluid biomarker studies of Alzheimer's disease

Choi YS, Choe LH, Lee KH.

Expert Rev Proteomics. 2010 Dec;7(6):919-29. doi: 10.1586/epr.10.75.

Diagnosis and biomarkers of predementia in Alzheimer's disease

Forlenza OV, Diniz BS, Gattaz WF.

BMC Med. 2010 Dec 22;8:89. doi: 10.1186/1741-7015-8-89.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias